These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25410605)

  • 1. A case-control study comparing the incidence of early symptoms in pancreatic and biliary tract cancer.
    Keane MG; Horsfall L; Rait G; Pereira SP
    BMJ Open; 2014 Nov; 4(11):e005720. PubMed ID: 25410605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of pancreaticobiliary cancers in Irish families with pathogenic BRCA1 and BRCA2 variants.
    Power R; Leavy C; Nolan C; White N; Clarke R; Cadoo KA; Gallagher DJ; Lowery MA
    Fam Cancer; 2021 Apr; 20(2):97-101. PubMed ID: 32918181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sociodemographic trends in the incidence of pancreatic and biliary tract cancer in UK primary care.
    Keane MG; Horsfall LJ; Rait G; Pereira SP
    PLoS One; 2014; 9(9):e108498. PubMed ID: 25268478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying symptoms associated with diagnosis of pancreatic exocrine and neuroendocrine neoplasms: a nested case-control study of the UK primary care population.
    Liao W; Clift AK; Patone M; Coupland C; González-Izquierdo A; Pereira SP; Hippisley-Cox J
    Br J Gen Pract; 2021 Nov; 71(712):e836-e845. PubMed ID: 34544691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags.
    Sogawa K; Takano S; Iida F; Satoh M; Tsuchida S; Kawashima Y; Yoshitomi H; Sanda A; Kodera Y; Takizawa H; Mikata R; Ohtsuka M; Shimizu H; Miyazaki M; Yokosuka O; Nomura F
    Br J Cancer; 2016 Oct; 115(8):949-956. PubMed ID: 27657339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of serum parameters panels for the early detection of pancreatic cancer.
    Zhang P; Zou M; Wen X; Gu F; Li J; Liu G; Dong J; Deng X; Gao J; Li X; Jia X; Dong Z; Chen L; Wang Y; Tian Y
    Int J Cancer; 2014 Jun; 134(11):2646-55. PubMed ID: 24615168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demographic, clinical, and pathological features of early onset pancreatic cancer patients.
    Ntala C; Debernardi S; Feakins RM; Crnogorac-Jurcevic T
    BMC Gastroenterol; 2018 Sep; 18(1):139. PubMed ID: 30208959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of incidence, mortality and survival for pancreatic and biliary tract cancers across Europe, with assessment of influence of revised European age standardisation on estimates.
    Minicozzi P; Cassetti T; Vener C; Sant M
    Cancer Epidemiol; 2018 Aug; 55():52-60. PubMed ID: 29777994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes associated with pancreatic ductal adenocarcinoma is just diabetes: Results of a prospective observational study in surgical patients.
    Dugnani E; Gandolfi A; Balzano G; Scavini M; Pasquale V; Aleotti F; Liberati D; Di Terlizzi G; Petrella G; Reni M; Doglioni C; Bosi E; Falconi M; Piemonti L
    Pancreatology; 2016; 16(5):844-52. PubMed ID: 27546476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brightline-2: a phase IIa/IIb trial of brigimadlin (BI 907828) in advanced biliary tract cancer, pancreatic ductal adenocarcinoma or other solid tumors.
    Yoo C; Lamarca A; Choi HJ; Vogel A; Pishvaian MJ; Goyal L; Ueno M; Märten A; Teufel M; Geng L; Morizane C
    Future Oncol; 2024; 20(16):1069-1077. PubMed ID: 38214149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct serum metabolomics profiles associated with malignant progression in the KrasG12D mouse model of pancreatic ductal adenocarcinoma.
    LaConti JJ; Laiakis EC; Mays AD; Peran I; Kim SE; Shay JW; Riegel AT; Fornace AJ; Wellstein A
    BMC Genomics; 2015; 16 Suppl 1(Suppl 1):S1. PubMed ID: 25923219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between use of statin or aspirin and pancreatic ductal adenocarcinoma: A nested case-control study in a Korean nationwide cohort.
    Choi JH; Lee SH; Huh G; Chun JW; You MS; Paik WH; Ryu JK; Kim YT
    Cancer Med; 2019 Dec; 8(17):7419-7430. PubMed ID: 31637875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in the incidence and management of biliary tract cancer: a French population-based study.
    Lepage C; Cottet V; Chauvenet M; Phelip JM; Bedenne L; Faivre J; Bouvier AM
    J Hepatol; 2011 Feb; 54(2):306-10. PubMed ID: 21056501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-free plasma microRNA in pancreatic ductal adenocarcinoma and disease controls.
    Carlsen AL; Joergensen MT; Knudsen S; de Muckadell OB; Heegaard NH
    Pancreas; 2013 Oct; 42(7):1107-13. PubMed ID: 24048453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of aspirin in the prevention of pancreatic cancer: A nested case-control study in the UK Biobank.
    Buckland GR; Wilding SA; McDonnell D; Hamady ZZR
    Pancreatology; 2024 Sep; 24(6):947-953. PubMed ID: 39155166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Trends in the Incidence and Survival of Stage 1A Pancreatic Cancer: A Surveillance, Epidemiology, and End Results Analysis.
    Blackford AL; Canto MI; Klein AP; Hruban RH; Goggins M
    J Natl Cancer Inst; 2020 Nov; 112(11):1162-1169. PubMed ID: 31958122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk.
    Gomez-Rubio P; Rosato V; Márquez M; Bosetti C; Molina-Montes E; Rava M; Piñero J; Michalski CW; Farré A; Molero X; Löhr M; Ilzarbe L; Perea J; Greenhalf W; O'Rorke M; Tardón A; Gress T; Barberá VM; Crnogorac-Jurcevic T; Muñoz-Bellvís L; Domínguez-Muñoz E; Gutiérrez-Sacristán A; Balsells J; Costello E; Guillén-Ponce C; Huang J; Iglesias M; Kleeff J; Kong B; Mora J; Murray L; O'Driscoll D; Peláez P; Poves I; Lawlor RT; Carrato A; Hidalgo M; Scarpa A; Sharp L; Furlong LI; Real FX; La Vecchia C; Malats N;
    Ann Oncol; 2017 Jul; 28(7):1618-1624. PubMed ID: 28383714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Circular RNAs in Pancreatic Ductal Adenocarcinoma and Biliary-Tract Cancers.
    Limb C; Liu DSK; Veno MT; Rees E; Krell J; Bagwan IN; Giovannetti E; Pandha H; Strobel O; Rockall TA; Frampton AE
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33158116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal trends of pancreatic ductal adenocarcinoma in young adults in the United States: A Population-Based Study.
    Gad MM; Saad AM; Al-Husseini MJ; Abdel-Gawad YM; Alsalhani OM; Alhaddad R; Mohamad B; Saleh MA; Simons-Linares CR
    Clin Res Hepatol Gastroenterol; 2020 Apr; 44(2):204-210. PubMed ID: 31420297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age distribution patterns of patients with conventional ductal adenocarcinoma of the pancreas. A single-institution study of 580 cases re-evaluated using current histopathological diagnostic criteria.
    Liszka Ł; Pająk J; Mrowiec S; Zielińska-Pająk E; Lampe P; Gołka D
    Pol J Pathol; 2010; 61(2):65-77. PubMed ID: 20924989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.